These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18803622)

  • 1. Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy.
    Jiang Y; Liang X; Li X; Tao Y; Wang K
    Acta Ophthalmol; 2009 Nov; 87(7):736-40. PubMed ID: 18803622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy.
    Oshima Y; Sakaguchi H; Gomi F; Tano Y
    Am J Ophthalmol; 2006 Jul; 142(1):155-8. PubMed ID: 16815267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
    Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
    J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab in the treatment of diabetic ocular neovascularization.
    Ababneh OH; Yousef YA; Gharaibeh AM; Abu Ameerh MA; Abu-Yaghi NE; Al Bdour MD
    Retina; 2013 Apr; 33(4):748-55. PubMed ID: 23296048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.
    Silva Paula J; Jorge R; Alves Costa R; Rodrigues Mde L; Scott IU
    Acta Ophthalmol Scand; 2006 Aug; 84(4):556-7. PubMed ID: 16879583
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of preoperative intravitreal bevacizumab on visual function in eyes with proliferative diabetic retinopathy.
    Ushida H; Kachi S; Asami T; Ishikawa K; Kondo M; Terasaki H
    Ophthalmic Res; 2013; 49(1):30-6. PubMed ID: 23038607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy.
    Falavarjani KG; Modarres M; Nazari H
    Eye (Lond); 2010 Apr; 24(4):717-9. PubMed ID: 19407842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.
    Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R
    Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
    Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
    Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
    Melamud A; Stinnett S; Fekrat S
    Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
    Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
    Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
    Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrasilicone bevacizumab injection for iris neovascularization after vitrectomy for proliferative diabetic retinopathy.
    Salman AG
    Ophthalmic Res; 2013; 49(1):20-4. PubMed ID: 22986803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral simultaneous intravitreal injections in the office setting.
    Bakri SJ; Risco M; Edwards AO; Pulido JS
    Am J Ophthalmol; 2009 Jul; 148(1):66-9.e1. PubMed ID: 19403114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up.
    Arevalo JF; Wu L; Sanchez JG; Maia M; Saravia MJ; Fernandez CF; Evans T
    Eye (Lond); 2009 Jan; 23(1):117-23. PubMed ID: 17891058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome.
    Amselem L; Montero J; Diaz-Llopis M; Pulido JS; Bakri SJ; Palomares P; Garcia-Delpech S
    Am J Ophthalmol; 2007 Jul; 144(1):122-4. PubMed ID: 17601432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma.
    Kitnarong N; Chindasub P; Metheetrairut A
    Adv Ther; 2008 May; 25(5):438-43. PubMed ID: 18425438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.